References
Bond AJ. Drug-induced behavioural disinhibition: incidence, mechanisms and therapeutic implications. CNS Drugs 1998; 9(1): 41–57
Rothschild AJ, Locke CA. Re-exposure to fluoxetine after serious suicide attempts by 3 patients: the role of akathisia. J Clin Psychiatry 1991; 52: 491–3
Wirshing WC, Van Putten T, Rosenberg J, et al. Fluoxetine, akathisia and suicidality: is there a causal connection? Arch Gen Psychiatry 1992; 49: 580–1
King RA, Riddle MA, Chappell PB, et al. Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment. J Am Acad Child Adolesc Psychiatry 1991; 30: 179–86
Creaney W, Murray I, Healy D. Antidepressant-induced suicidal ideation. Hum Psychopharmacol 1991; 6: 329–32
Ashleigh EA, Fesler FA. Fluoxetine and suicidal preoccupation. Am J Psychiatry 1992; 149: 1750
Beasley CM, Potvin JH, Masica DN, et al. Fluoxetine: no association with suicidality in obsessive-compulsive disorder. J Affect Disord 1992; 24: 1–10
Beasley CM, Domseif BE, Bosomworth JC, et al. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. BMJ 1991; 303: 685–92
Cornelius JR, Salloum TM, Cornelius MD, et al. Fluoxetine trial in suicidal depressed alcoholics. Psychopharmacol Bull 1993; 2: 195–9
Dunbar GC, Mewett S. Suicidal thoughts and behaviour with paroxetine. Biol Psychiatry 1991; 29: 333S
Fava M, Rosenbaum JF. Suicidality and fluoxetine: is there a relationship? J Clin Psychiatry 1991; 52: 108–11
Filteau M-J, Lapierre YD, Bakish D, et al. Reduction in suicidal ideation with SSRIs: a review of 459 depressed patients. J Psychiatric Neurosci 1993; 18: 114–9
Goldstein D, Rampey AH, Potvin JH, et al. Analyses of suicidality in double-blind, placebo-controlled trials of pharmacotherapy for weight reduction. J Clin Psychiatry 1993; 309-16
Jick H, Ulcickas M, Dean A. Companion of frequencies of suicidal tendencies among patients receiving fluoxetine, lofepramine, mianserin, or trazodone. Pharmacotherapy 1992; 12: 451–4
Jick SS, Dean AD, Jick H. Antidepressants and suicide. BMJ 1995; 310: 215–8
Kapur S, Mieczkowaki T, Mann JJ. Antidepressant medications and the relative risk of suicide attempts and suicide. JAMA 1992; 268: 3441–5
Kuha S, Mehtonen O-P, Henttonen A, et al. The efficacy of fluoxetine versus maprotiline in depressed patients and by dose. Nord Psykiatr Tidsskr 1991; 45: 109–17
Marzuk PM, Tardiff K, Leon AC, et al. Use of prescription psychotropic drugs among suicide victims in New York City. Am J Psychiatry 1995; 152: 1520–2
Masica DN, Kotsanos JG, Beasley Jr CM, et al. Trend in suicide rates since fluoxetine introduction. Am J Pub Health 1992; 82: 1295
Morton WA, Sonne SC, Lydiard RB. Fluoxetine-associated side effects and suicidality. J Clin Psychopharmacol 1993; 13: 292–5
Muljen M, Roy D, Silverstone T, et al. A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients. Acta Psychiatr Scand 1988; 78: 384–90
Sacchetti E, Guarneril VA. The effectiveness of fluoxetine, clomipramine, nortriptyline and desipramine in major depressives with suicidal behavior: preliminary findings. In: Cassano GB, Akiskal HS, editors. Serotonin-related psychiatric syndromes: clinical and therapeutic links. Royal Society of Medicine Services, 1991
Tollefson GD, Rampey AH, Beasley EGG, et al. Absence of a relationship between adverse events and suicidality during pharmacotherapy for depression. J Clin Psychopharmacol 1994; 14: 163–9
Tollefson GD, Tollefson SL, Sayler ME, et al. Absence of emergent suicidal ideation during treatment: a comparative controlled double blind analysis employing several distinct anti-depressants. Depression 1994; 2: 73–9
Tollefson GD, Fawcett J, Winokur G, et al. Evaluation of suicidality during pharmacologic treatment of mood and non-mood disorder. Ann Clin Psychiatry 1993; 4: 209–24
Tollefson GD, Greist JH, Jefferson JW, et al. Is baseline agitation a relative contraindication for a selective serotonin reuptake inhibitor? A comparative trial of fluoxetine versus imipramine. J Clin Psychopharmacol 1994; 14: 385–91
Warshaw MG, Keller MB. The relationship between fluoxetine use and suicidal behavior in 654 subjects with anxiety disorders. J Clin Psychiatry 1995; 57: 158–66
Wheadon DE, Rampey Jr AH, Thompson VL, et al. Lack of association between fluoxetine and suicidality in bulimia nervosa. J Clin Psychiatry 1992; 53: 235–41
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Beasley, C.M. Suicidality with Fluoxetine. Mol Diag Ther 9, 513 (1998). https://doi.org/10.2165/00023210-199809060-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00023210-199809060-00007